Drug intelligence / Profile preview

prilocaine hydrochloride

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Epidural, Intradermal, Intrathecal, Parenteral, Subcutaneous
01

Overview

Prilocaine hydrochloride is an intermediate-acting local anesthetic of the amide class, chemically related to lidocaine. It acts by binding to the intracellular portion of voltage-gated sodium channels in the neuronal membrane, preventing sodium influx during depolarization. This stabilizes the membrane and inhibits the initiation and conduction of nerve impulses, resulting in a reversible local anesthetic effect. Prilocaine is widely used for infiltration anesthesia, peripheral nerve blocks, and spinal/epidural anesthesia, particularly in dental and minor surgical procedures. It is characterized by a rapid onset and moderate duration of action, with lower cardiotoxicity compared to some other amide anesthetics, though its metabolism can lead to the formation of o-toluidine, which carries a risk of inducing methemoglobinemia.

Brand names
CitanestPrilocPrilotekalXylonest
Other names
N-(2-methylphenyl)-2-(propylamino)propanamide hydrochloridePriloc HCl %2prilocaineprilocaine HClprilocaine hydrochloridepropitocainepropitocaine hydrochloride
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on prilocaine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prilocaine hydrochloride.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call